Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
The current Regeneron(REGN) stock price is $674.90, with a market capitalization of 70.79B. The stock trades at a price-to-earnings (P/E) ratio of 16.54 and offers a dividend yield of 0.54%.
On 2026-07-22, Regeneron(REGN) stock moved within a range of $666.88 to $678.67. With shares now at $674.90, the stock is trading +1.2% above its intraday low and -0.6% below the session's peak.
Trading activity shows a volume of 529.6K, compared to an average daily volume of 617.41K.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $821.11 and a low of $541.00.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $821.11 and a low of $541.00.
REGN News
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, mo...
Guggenheim analyst Yatin Suneja raised the firm’s price target on Regeneron (REGN) to $1,000 from $995 and keeps a Buy rating on the shares. The firm is revisin...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is facing a federal securities lawsuit over allegations that investors were misled about a Phase III trial testin...
Analyst ratings
67%
of 30 ratingsMore REGN News
Regeneron Pharmaceuticals (REGN), Sanofi (SNYNF) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to...
Biohaven (BHVN) has entered into a clinical supply agreement with Regeneron Pharmaceuticals (REGN) to evaluate the combination of BHV-1530 and cemiplimab, or Li...
...
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Regeneron Pharmaceuticals, Inc. (Symbol: REGN) has take...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.